Market Overview
Animal Vaccines ensure the healthy state of the animal and reduce animal suffering. Furthermore, vaccines enable efficient production of animals to feed the expanding human population and eliminate the need for antibiotics to heal food & companion animals.
According to MarkNtel Advisors’ research report, “Global Animal Vaccines Market Analysis, 2021,” the market is likely to grow at a CAGR of around 7.4% in the forecast period of 2021-26. The expanding bursts of cattle disease and the constantly expanding livestock population are the prime factors behind the wide acceptance of vaccines throughout the globe. Besides, the rising trend of pet ownership is also increasing the awareness for domestic animals’ health, thereby propelling the market growth. Furthermore, the escalating number of R&D investments initiated by the governments & companies is another potential growth factor of the Global Animal Vaccine Market.
Impact of COVID-19
The outbreak of the COVID-19 pandemic has adversely affected various industries. Several countries across the globe imposed nationwide lockdowns, which then led to multiple challenges, supply chain disruptions, and trade limitations in every business. Similarly, the Global Animal Vaccines Market got negatively hit by the pandemic. All veterinary organizations restricted animal care services to acutely ill animals and emergencies. However, investments, support, and funding by various key players have ensured an easy supply flow of animal vaccines to avoid zoonotic viruses from spreading into communities.
Market Segmentation
Recombinant Vaccines to attain the Fastest Market Growth
Based on the Technology, the Global Animal Vaccine Market segments into Live Attenuated Vaccines, Livestock Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Others (DNA vaccines). Of all, Recombinant Vaccines are more likely to attain the fastest growth in the forecast period. These vaccines reduce the risk of pathogenicity in animals and fight against multiple virus strains. The formulations can avoid the need for adjuvants, increase the viability of the vaccine, and enhance stability. Hence, the demand for Recombinant Vaccines is propelling globally, and they are likely to attain the fastest growth in the market during the forecast period.
Ruminants Vaccines to Hold the Largest Market Share
Based on the Type, the Global Animal Vaccine Market segments into Porcine Vaccines, Aquaculture Vaccines, Ruminants Vaccines, Companion Animals Vaccines (Canine Vaccines, Feline Vaccines, Poultry Vaccines), Livestock Vaccines. Out of all, Ruminants Vaccines are likely to hold the largest market share in the forecast period. It owes to prominent factors like the booming livestock population, encouraging government initiatives, and the outbreak of diseases, thereby accelerating the demand for this segment, reveals MarkNtel Advisors research report, “Global Animal Vaccines Market Analysis, 2021.”
Regional Landscape
North America Accounted for the Largest Market Share
North America dominated the market in the previous few years with the largest market share and is likely to continue the position in the forecast years. It majorly owes to the significant prevalence of livestock diseases that is leading to large-scale animal deaths. Besides, the abundant presence of well-established pharmaceutical firms strives for better commercialization of their vaccines and augment global reach. These factors are likely to drive the market in the North American region. Furthermore, the rapidly increasing incidence of canine disorders, resulting in the adoption of vaccination, and the growing pet population in the US are a few critical factors seeking the expansion of the animal vaccine market share of the region.
Market Driver
The Global Animal Vaccine Market is highly competitive and marked by multiple small and large animal vaccine manufacturers for investment and support. The key factors influencing the market growth and competition are the constantly growing adoption of veterinary preventive injections and government-aided bulk purchases.
Competitive Landscape
According to MarkNtel Advisors, the leading players in the Global Animal Vaccines Market are Elanco, Ceva, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd., Biog?nesis Bag?, Ourofino Sa?de Animal, Virbac, Zoetis, Merc & Co., Inc., Boehringer Ingelheim International GmbH.
Key Questions Answered in the Market Research Report:
1. What are the overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Animal Vaccines Market?
2. What are the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Animal Vaccines Market?
4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Animal Vaccines Market based on the competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Animal Vaccines Market study?
Market Outlook, Segmentation, and Statistics
1. Impact of COVID-19 on Global Animal Vaccines Market
2. Market Size & Analysis
2.1. By Revenue
3. Market Share & Analysis
3.1. By Type
3.1.1. Porcine Vaccines
3.1.2. Aquaculture Vaccines
3.1.3. Ruminants Vaccines
3.1.4. Companion Animals Vaccines
3.1.5. (Canine Vaccines, Feline Vaccines, Poultry Vaccines)
3.1.6. Livestock Vaccines
3.2. By Diseases
3.2.1. Porcine Diseases
3.2.2. Aquaculture Diseases
3.2.3. Ruminants Diseases
3.2.4. Companion Animals Diseases
3.2.5. (Canine Diseases, Feline Diseases)
3.2.6. Poultry Diseases, Livestock Diseases
3.3. By Technology
3.3.1. Live Attenuated Vaccines
3.3.2. Livestock Inactivated Vaccines
3.3.3. Toxoid Vaccine
3.3.4. Recombinant Vaccines
3.3.5. Other (DNA vaccines)
3.4. By Region
3.4.1. North America Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.1.1. The US Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.1.2. Canada Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.2. South America Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.2.1. Brazil Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.3. Europe Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.3.1. The UK Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.3.2. Germany Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.3.3. France Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.4. Asia-Pacific Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.4.1. China Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.4.2. South Korea Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.4.3. Japan Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.4.5. The Middle East & Africa Animal Vaccines Market Outlook, 2016-2026F (USD Million)
3.5. By Competitors
3.5.1. Competition Characteristics
3.5.2. Market Share & Analysis
3.5.3. Competitive Matrix
4. Global Animal Vaccines Market Hotspots & Opportunities
5. Global Animal Vaccines Market Regulations & Policy
6. Key Strategic Imperatives for Success and Growth
7. Global Competition Outlook
7.1. Competition Matrix
7.2. Company Profile